10% owner BIOTECH GROWTH N V sells entire 7,879,583-share stake (100% of holdings) for $12,018,409.08
BIOTECH GROWTH N V executed 4 separate sales on 2024-11-01, liquidating its complete 7.88M-share position for $12.0M at a blended average price of $1.53 per share. This represents a full exit by a 10% stakeholder, reducing holdings from 7,879,583 shares to 0 shares post-transaction. The timing is notable: the current price of $1.70 is -84.0% from the 52-week high of $10.65, and the stock has declined -71.8% over the prior 30 days and -62.6% over the prior 90 days. Additionally, ESSA Pharma reported net income of $-7,233,747.00 for its most recent full fiscal year, indicating the company remains unprofitable. The insider's cross-ticker track record shows 3 prior buys with an average 90-day return of -18.5% and a 33.33% win rate, though no same-ticker historical comparison is available to contextualize this specific divestiture against prior EPIX holdings.